<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASeed_funding</id>
	<title>Definition:Seed funding - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASeed_funding"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Seed_funding&amp;action=history"/>
	<updated>2026-04-30T02:46:25Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Seed_funding&amp;diff=16992&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Seed_funding&amp;diff=16992&amp;oldid=prev"/>
		<updated>2026-03-15T08:39:41Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🌱 &amp;#039;&amp;#039;&amp;#039;Seed funding&amp;#039;&amp;#039;&amp;#039; is the earliest formal round of external capital raised by an [[Definition:Insurtech | insurtech]] startup, used to finance initial product development, team building, [[Definition:Regulatory | regulatory]] groundwork, and early market validation before the company has generated significant [[Definition:Premium | premium]] volume or revenue. In the insurance industry, seed-stage capital is particularly consequential because insurtechs face a distinctive set of startup costs — including [[Definition:Insurance license | licensing]] or partnership arrangements with [[Definition:Insurance carrier | carriers]], [[Definition:Compliance | compliance]] infrastructure, and [[Definition:Actuarial | actuarial]] modeling — that pure-play technology startups do not encounter. Seed rounds for insurtechs typically range from several hundred thousand dollars to a few million, sourced from [[Definition:Angel investor | angel investors]], specialized insurtech accelerators, [[Definition:Venture capital | venture capital]] funds, and increasingly from [[Definition:Corporate venture capital (CVC) | corporate venture capital]] arms of established insurers and [[Definition:Reinsurer | reinsurers]].&lt;br /&gt;
&lt;br /&gt;
⚙️ Capital raised at the seed stage is deployed against a set of milestones designed to de-risk the business enough to attract a larger [[Definition:Series A | Series A]] investment. For an insurtech [[Definition:Managing general agent (MGA) | MGA]], this might mean securing a [[Definition:Binding authority agreement | binding authority agreement]] with a capacity provider, building a minimum viable [[Definition:Policy administration system | policy administration system]], and writing the first tranche of policies to demonstrate [[Definition:Loss ratio | loss ratio]] performance. For a claims-technology or data-analytics startup, seed funding might support building a prototype, onboarding pilot customers from the carrier or [[Definition:Broker | broker]] community, and establishing proof points around cost savings or accuracy improvements. Investment instruments at this stage commonly include [[Definition:SAFE (Simple Agreement for Future Equity) | SAFEs]], [[Definition:Convertible note | convertible notes]], or occasionally priced [[Definition:Preferred stock | preferred equity]] rounds, with the choice depending on market norms, investor preferences, and the startup&amp;#039;s jurisdiction.&lt;br /&gt;
&lt;br /&gt;
💡 The quality and source of seed funding can shape an insurtech&amp;#039;s trajectory far beyond the dollars involved. A seed investment from a reinsurer&amp;#039;s venture arm or a well-connected industry accelerator brings not just capital but access to [[Definition:Underwriting | underwriting]] capacity, distribution relationships, regulatory expertise, and credibility with future investors. Conversely, taking seed capital from investors unfamiliar with the insurance sector&amp;#039;s regulatory complexity and long sales cycles can create misaligned expectations around growth timelines. The global insurtech seed market has matured considerably: hubs in London, New York, Singapore, and Berlin have developed ecosystems where founders can access insurance-savvy capital, mentorship, and [[Definition:Regulatory sandbox | regulatory sandbox]] programs. Ultimately, seed funding represents the inflection point where an insurance innovation concept transitions from idea to operating entity — a bridge between ambition and the institutional rigor the industry demands.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:SAFE (Simple Agreement for Future Equity)]]&lt;br /&gt;
* [[Definition:Venture capital]]&lt;br /&gt;
* [[Definition:Series A]]&lt;br /&gt;
* [[Definition:Insurtech]]&lt;br /&gt;
* [[Definition:Corporate venture capital (CVC)]]&lt;br /&gt;
* [[Definition:Angel investor]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>